Lawyer Profile
Lisa Melanson
Toronto, Ontario
Overview
Under the agreement of this take-private transaction worth C$9 billion, Boralex will continue to operate as an independent private company following closing.
Our Outlook Series 2026 provides forward‑looking analysis of the most important legal, regulatory, and market developments affecting Canadian organizations.
Lisa Melanson is a partner in our Intellectual Property Group in Toronto. Her interdisciplinary practice encompasses the areas of intellectual property and product regulation.
Lisa's intellectual property work focuses on the global acquisition, exploitation, enforcement, and defence of patent and other intellectual property rights. She provides clients with strategic, common-sense advice concerning all phases of patent procurement and protection, from conception to commercialization. She has considerable experience conducting large-scale patentability, infringement, validity, and freedom-to-operate analyses and preparing IP and regulatory landscapes. She also provides IP support on patent litigation matters and IP and regulatory assistance on corporate and commercial transactions, including mergers and acquisitions. She has particular expertise advising pharma clients at the complex interface of drug regulation, patent prosecution, and litigation under the Patented Medicines (Notice of Compliance) Regulations.
In her regulatory practice, Lisa advises importers, retailers, manufacturers, and other clients on the regulation of a broad range of products. As a scientist and patent lawyer, Lisa offers a one-stop shop for innovative clients who wish to patent new products and bring them to market. She has considerable experience obtaining patent protection for, and advising on regulatory matters relating to, food and drugs, natural health products, cosmetics, medical devices, electrical equipment, and veterinary products. While cannabis practice is new to many, it is not new to Lisa: she has two decades of experience in the regulation of drugs and controlled substances. She and her team rely on their legal and technical expertise to guide clients through the new cannabis regulatory framework with confidence.
Practice Areas
Bar Information
Called to the bar: 1997 (NS); 2001 (NY); 2005 (ON)